Original language | English |
---|---|
Pages (from-to) | 20-21 |
Number of pages | 2 |
Journal | Blood |
Volume | 136(Supplement 1) |
DOIs | |
State | Published - 5 Nov 2020 |
Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)
Jakub Svoboda, Stefan K. Barta, Daniel J. Landsburg, Sunita Dwivedy Nasta, Wei Hwang, Grace Delp, Brittany Amundsen, Hatcher J. Ballard, James N. Gerson, Elise A. Chong, Mitchell E. Hughes, Steven A. Emanuel, Marco Ruella, Stephen J. Schuster
Research output: Contribution to journal › Meeting Abstract › peer-review